Genetic Technologies Ltd (GENE)

Genetic Technologies Ltd (GENE) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.7M; returns 1 day -0.2%, 1 week +0.8%, 1 year +13.8%.

Genetic Technologies Ltd (GENE) is an Australian molecular diagnostics company currently in a state of severe financial and operational transition. As of March 2026, the company is operating under a Deed of Company Arrangement (DOCA) following a period of voluntary administration that began in late 2024.

Groups GENE belongs to

• Clinical Stage Biotech
• Biotechnology
• Life Sciences
• Biopharmaceutical
• Healthcare Technology
• Health Diagnostics and Imaging
• Personalized Medicine

GENE financial model: income statement, cash flow and balance sheet